New York, New York–(Newsfile Corp. – January 14, 2025) – WHY: Rosen Law Firm, a global investor…
Tag: Sciences
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York–(Newsfile Corp. – January 1, 2025) – WHY: Rosen Law Firm, a global investor…
Roivant Sciences’ president sells common shares worth $4.1 million By Investing.com
Eric Venker, the President and Chief Operating Officer of Roivant Sciences Ltd. (NASDAQ:), recently executed a…
A Securities Fraud Class Action Lawsuit Was Filed Against Cassava Sciences, Inc. (SAVA) By Investing.com
RADNOR, PA – (NewMediaWire) – December 30, 2024 – The law firm of Kessler Topaz Meltzer…
Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise
Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise #Gilead #Sciences #Preview #Buy #Thriving…
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor…
SAVA Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc. (SAVA)
RADNOR, PA – (NewMediaWire) – December 28, 2024 – The law firm of Kessler Topaz Meltzer…